Get the Stockscreener App
353.86
3.34%
11.45
After Hours:
353.86
Bio Rad Laboratories Inc stock is traded at $353.86, with a volume of 142.71K.
It is up +3.34% in the last 24 hours and up +8.06% over the past month.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
See More
Previous Close:
$342.41
Open:
$344.51
24h Volume:
142.71K
Relative Volume:
0.83
Market Cap:
$9.91B
Revenue:
$2.58B
Net Income/Loss:
$-778.69M
P/E Ratio:
-12.95
EPS:
-27.33
Net Cash Flow:
$223.75M
1W Performance:
+3.40%
1M Performance:
+8.06%
6M Performance:
+19.22%
1Y Performance:
+15.41%
1-Day Range:
$342.95
$354.73
1-Week Range:
$334.57
$354.73
52-Week Range:
$262.12
$387.99
Bio Rad Laboratories Inc Stock (BIO) Company Profile
Name
Bio Rad Laboratories Inc
Sector
Industry
Phone
(510) 724-7000
Address
1000 ALFRED NOBEL DRIVE, HERCULES
Compare BIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BIO
Bio Rad Laboratories Inc
|
353.86 | 9.91B | 2.58B | -778.69M | 223.75M | -27.33 |
|
ABT
Abbott Laboratories
|
116.79 | 201.01B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
395.85 | 150.90B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
100.91 | 148.72B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
88.38 | 113.33B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
69.97 | 41.27B | 6.60B | 4.16B | 490.10M | 6.93 |
Bio Rad Laboratories Inc Stock (BIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-01-24 | Upgrade | Citigroup | Neutral → Buy |
| Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Apr-03-24 | Downgrade | Citigroup | Buy → Neutral |
| Dec-07-23 | Initiated | UBS | Buy |
| Jun-16-23 | Initiated | Wells Fargo | Overweight |
| Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Jan-28-22 | Reiterated | Citigroup | Buy |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Oct-17-18 | Initiated | Goldman | Buy |
| Sep-20-18 | Initiated | Morgan Stanley | Equal-Weight |
| Feb-16-18 | Downgrade | CL King | Buy → Neutral |
| Jul-13-17 | Initiated | Wells Fargo | Outperform |
| Jun-28-17 | Upgrade | Deutsche Bank | Hold → Buy |
| Jan-18-17 | Initiated | Deutsche Bank | Hold |
| Oct-13-16 | Initiated | CL King | Buy |
| May-06-15 | Reiterated | Jefferies | Buy |
| Dec-18-09 | Initiated | Maxim Group | Buy |
| Nov-06-09 | Initiated | Jefferies & Co | Buy |
| Jul-17-09 | Initiated | Soleil | Buy |
| Sep-26-07 | Initiated | Banc of America Sec | Buy |
| Feb-23-07 | Downgrade | Robert W. Baird | Outperform → Neutral |
View All
Bio Rad Laboratories Inc Stock (BIO) Latest News
High Throughput Screening (HTS) Market Innovations and Key - openPR
Bio-Rad Laboratories (NYSE:BIO.B) Shares Gap DownHere's What Happened - MarketBeat
Enhance Lab Efficiency with Bio-Rad’s Vericheck ddPCR™ Kits for AAV2 and AAV8 - Lab Manager Magazine
Understanding the Nuts and Bolts of qPCR Assay Controls - The Scientist
Biomarker Testing Market Projected to Reach Huge Growth by 2031 - openPR
Laboratory Equipment Market: Projected Significant CAGR with - openPR
Saudi Arabia IVD Market Outlook & Company Analysis 2025-2033, Featuring Roche Diagnostics, Danaher, Abbott Laboratories, Thermo Fischer Scientific, Bio-Rad Laboratories, Sysmex, Becton and Biomerieux - Yahoo Finance
Bio-Rad Laboratories, Inc. (NYSE:BIO) Short Interest Up 18.8% in December - MarketBeat
Malaria Diagnostics Market Investment Opportunities: A Guide to 2031 | Nikon Corporation, Bio-Rad Laboratories - EIN News
RNA Transcriptome Profiling Tests Market Expands at 14.5% CAGR, Surpassing US$ 37 Billion by 2034 | Fact.MR Report - GlobeNewswire Inc.
Why Bio-Rad Stock is an Apt Pick for Your Portfolio Right Now - MSN
Wedge Capital Management L L P NC Takes $28.74 Million Position in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
Geneoscopy, Inc. announced that it expects to receive $120.850521 million in funding -October 30, 2024 - Marketscreener.com
Is Adaptive Biotechnologies (ADPT) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Bio-Rad Launches Nuvia wPrime 2A Media for Biomolecule Purification - Technology Networks
Biotech bi-weekly: 2025 launches with a deluge of industry partnerships - BioTechniques
Contravisory Investment Management Inc. Takes Position in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
Research Analysts Set Expectations for BIO FY2024 Earnings - MarketBeat
Bio-Rad launches Nuvia wPrime 2A Media for biomolecule purification - SelectScience
Next Generation Sequencing Market Size, Share, Industry - openPR
Genomics Market Is Expected To Reach USD 115.4 Billion By 2031Agilent Technologies, Bio-Rad Laboratories Inc - openPR
Genetic Testing Market: Projected Positive Growth Trends - openPR
Laboratory Equipment and Disposables Market Overall Study - openPR
Bio-Rad launches Nuvia wPrime 2A media for biomolecule purification - Cambridge Network
Sample Preparation Market Generated Opportunities, Future Scope by 2031 | F. Hoffmann-La Roche AG, Bio-Rad - EIN News
The Analyst Verdict: Bio-Rad Laboratories In The Eyes Of 4 Experts - Benzinga
Bio-Rad Laboratories' (BIO) "Outperform" Rating Reaffirmed at Royal Bank of Canada - MarketBeat
Animal Health Diagnostics Market to grow by USD 2.1 Billion (2025-2029), driven by rising pet humanization, report highlights AI-driven market trendsTechnavio - The Malaysian Reserve
(BIO) Technical Data - Stock Traders Daily
Microfluidic Devices Market Global Outlook 2025-2035, with Company Profiles of the Top 10+ Major Market Players - GlobeNewswire
Expanded range of prepacked chromatography columns for biotherapeutic purification - Labmate Online
JPMorgan Chase & Co. Sells 4,840 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
Biosensors Market Overall Study Report 2024-2031 | Bio-Rad Laboratories Inc., Medtronic - EIN News
Diversified Trust Co Takes $958,000 Position in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
Flow Cytometry in Oncology and Immunology Market Top Players - openPR
HIV Diagnostics Test Market Is Booming Worldwide 2025-2032 | - openPR
Global cDNA Reverse Transcription Kit Market Size 2025-2032: Man - WICZ
Growth Trends in the Pediatric Cancer Biomarkers Market, - GlobeNewswire
Growth Trends in the Pediatric Cancer Biomarkers Market, 2024-2034Roche, Thermo Fisher Scientific, Illumina, QIAGEN, and Bio-Rad Laboratories Dominate the Competition - Yahoo Finance
Laboratory Supplies Market Overall Study Report 2025-2032 | - openPR
Bio-Rad Laboratories (NYSE:BIO.B) Shares Gap UpShould You Buy? - MarketBeat
Geneoscopy Closes $105M in Series C Funding Round to Power Next-Generation of Gastrointestinal Diagnostic Tests - Business Wire
Bio-Rad extends range of Foresight Pro prepacked chromatography columns for biotherapeutic production - SelectScience
DNA Methylation Market Set to Witness Significant Growth - openPR
Bio-Rad Extends Range of Foresight Pro Prepacked Chromatography Columns for Biotherapeutic Production - Technology Networks
Geneoscopy Raises $105M to Launch Revolutionary Non-Invasive Cancer Screening Test ColoSense - StockTitan
Biomarker Research Services Market Generated Opportunities, - openPR
Bio-Rad Expands Chromatography Columns for Biotherapeutic Production - Contract Pharma
Cell Culture Market Top PlayersCargill Inc., Bio-Rad Laboratories, Inc.; Thermo Fisher Scientific, Inc.; Becton. - openPR
Getting In Cheap On Bio-Rad Laboratories, Inc. (NYSE:BIO) Is Unlikely - Simply Wall St
CEACAM8 Antigen Gene Market Top PlayersThermo Fisher - openPR
Bio Rad Laboratories Inc Stock (BIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):